Skip to main content
Top
Published in: Cancer Causes & Control 3/2010

01-03-2010 | Original paper

Timeliness and follow-up patterns of cervical cancer detection in a cohort of medically underserved California women

Authors: Farzaneh Tabnak, Hans-Georg Müller, Jane-Ling Wang, Weihong Zhang, Lydia Pleotis Howell

Published in: Cancer Causes & Control | Issue 3/2010

Login to get access

Abstract

Introduction

This study examines factors associated with timely follow-up after Pap test in a program providing cervical cancer detection services to medically underserved California women.

Methods

Data between 01 January 1992 and 30 June 2007 were analyzed. Cox proportional hazard regression was used to identify subgroups of women with delayed time to diagnosis or treatment scheduling. The probability of being scheduled for final diagnosis and treatment was assessed using logistic regression analysis. Demographic and clinical characteristics of the women lost to follow up were examined.

Results

Time from screening to final diagnosis scheduling differed according to age group, race/ethnicity, and Pap test result. Race/ethnicity and age were associated with whether treatment was scheduled or not. While loss to follow up among those scheduled for final diagnosis was associated with certain patients’ characteristics, no such association was found among those who were scheduled for treatment.

Conclusions

Patient’s demographic characteristics determine the odds of being scheduled for final diagnosis and treatment as well as timeliness of follow-up from screening to final diagnosis. Findings suggest that the dual goal of reducing health disparities and cost-effective detection and treatment of precancerous disease to prevent cervical cancers cannot be achieved without consideration of racial/ethnic differences and needs.
Literature
2.
go back to reference Christopherson WM, Lundin FE, Mendez WM, Parker JE (1976) Cervical cancer control: a study of morbidity and trends over a twenty-one year period. Cancer 38:1357–1366CrossRefPubMed Christopherson WM, Lundin FE, Mendez WM, Parker JE (1976) Cervical cancer control: a study of morbidity and trends over a twenty-one year period. Cancer 38:1357–1366CrossRefPubMed
3.
go back to reference Clarke EA, Anderson TW (1979) Does screening by “Pap” test help prevent cervical cancer? a case-control study. Lancet 2:1–4CrossRefPubMed Clarke EA, Anderson TW (1979) Does screening by “Pap” test help prevent cervical cancer? a case-control study. Lancet 2:1–4CrossRefPubMed
4.
go back to reference Boyes DA (1981) The value of a Pap test program and suggestions for its implementation. Cancer 48(suppl):613–621CrossRefPubMed Boyes DA (1981) The value of a Pap test program and suggestions for its implementation. Cancer 48(suppl):613–621CrossRefPubMed
5.
go back to reference Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ (2001) ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 287:2120–2129CrossRef Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ (2001) ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 287:2120–2129CrossRef
6.
go back to reference ACOG Practice Bulletin number 66, September 2005 (2005) Management of abnormal cervical cytology and histology. Obstet Gynecol 106:645–664 ACOG Practice Bulletin number 66, September 2005 (2005) Management of abnormal cervical cytology and histology. Obstet Gynecol 106:645–664
7.
go back to reference Yabroff KR, Washington KS, Leader A, Neilson E, Mandelblatt A (2003) Is the promise of cancer screening program being compromised? quality of follow-up care after abnormal screening results. Med Care Res Rev 60:294–331CrossRefPubMed Yabroff KR, Washington KS, Leader A, Neilson E, Mandelblatt A (2003) Is the promise of cancer screening program being compromised? quality of follow-up care after abnormal screening results. Med Care Res Rev 60:294–331CrossRefPubMed
8.
go back to reference Marcus AC, Crane LA (1998) A review of cervical cancer screening intervention research: implications for public health programs and potential research. Prev Med 27:13–31CrossRefPubMed Marcus AC, Crane LA (1998) A review of cervical cancer screening intervention research: implications for public health programs and potential research. Prev Med 27:13–31CrossRefPubMed
9.
go back to reference Howell LP, Gurusinghe S, Tabnak F (2009) Impact of ASC-H terminology on the detection of HSILs in medically underserved California women. Diagn Cytopathol 37(2):103–110CrossRefPubMed Howell LP, Gurusinghe S, Tabnak F (2009) Impact of ASC-H terminology on the detection of HSILs in medically underserved California women. Diagn Cytopathol 37(2):103–110CrossRefPubMed
10.
go back to reference Fox P, Arnsberger P, Zhang XL (1997) Am examination of differential follow-up rates in cervical cancer screening. J Community Health 22(3):199–209CrossRefPubMed Fox P, Arnsberger P, Zhang XL (1997) Am examination of differential follow-up rates in cervical cancer screening. J Community Health 22(3):199–209CrossRefPubMed
11.
go back to reference Mandelblatt J, Kerner J, Zauber A, Burnett W (1991) Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health 81(5):646–649CrossRefPubMed Mandelblatt J, Kerner J, Zauber A, Burnett W (1991) Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health 81(5):646–649CrossRefPubMed
12.
go back to reference Carey P, Gjerdingen DK (1993) Follow-up of abnormal Papanicolaou tests among women of different races. J Fam Pract 37:583–589PubMed Carey P, Gjerdingen DK (1993) Follow-up of abnormal Papanicolaou tests among women of different races. J Fam Pract 37:583–589PubMed
13.
go back to reference McDougal JA, Mdeleine MM, Daling JR, Li CI (2007) Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992–2003. Cancer Causes Control 18:1175–1186CrossRef McDougal JA, Mdeleine MM, Daling JR, Li CI (2007) Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992–2003. Cancer Causes Control 18:1175–1186CrossRef
14.
go back to reference Mitchell J, McCormack LA (1997) Time trends in late-stage diagnosis of cervical cancer: differences by race ethnicity and income. Med Care 35(12):1220–1224CrossRefPubMed Mitchell J, McCormack LA (1997) Time trends in late-stage diagnosis of cervical cancer: differences by race ethnicity and income. Med Care 35(12):1220–1224CrossRefPubMed
15.
go back to reference Hiatt RA, Pasick RJ, Stewart S et al (2001) Community based cancer screening for underserved women: design and baseline findings from the breast and cervical intervention study. Prev Med 33:190–203CrossRefPubMed Hiatt RA, Pasick RJ, Stewart S et al (2001) Community based cancer screening for underserved women: design and baseline findings from the breast and cervical intervention study. Prev Med 33:190–203CrossRefPubMed
16.
go back to reference Zapka JG, Puleo E, Taplin SH, Goins KC, Yood MU (2004) Processes of care in cervical and breast cancer screening and follow-up–the importance of communication. Prev Med 39:81–90CrossRefPubMed Zapka JG, Puleo E, Taplin SH, Goins KC, Yood MU (2004) Processes of care in cervical and breast cancer screening and follow-up–the importance of communication. Prev Med 39:81–90CrossRefPubMed
17.
go back to reference Bastani R, Yabroff KR, Myers RE, Glenn B (2004) Interventions to improve follow-up of abnormal findings in cancer screening. Cancer 101(5 Suppl):1188–1200CrossRefPubMed Bastani R, Yabroff KR, Myers RE, Glenn B (2004) Interventions to improve follow-up of abnormal findings in cancer screening. Cancer 101(5 Suppl):1188–1200CrossRefPubMed
18.
go back to reference Tanjasiri SP, Tran JH, Kagawa-Singer M et al (2004) Exploring access to cancer control services for Asian-American and Pacific Islander communities in southern California. Ethn Dis 14:S14–S19PubMed Tanjasiri SP, Tran JH, Kagawa-Singer M et al (2004) Exploring access to cancer control services for Asian-American and Pacific Islander communities in southern California. Ethn Dis 14:S14–S19PubMed
Metadata
Title
Timeliness and follow-up patterns of cervical cancer detection in a cohort of medically underserved California women
Authors
Farzaneh Tabnak
Hans-Georg Müller
Jane-Ling Wang
Weihong Zhang
Lydia Pleotis Howell
Publication date
01-03-2010
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 3/2010
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9473-1

Other articles of this Issue 3/2010

Cancer Causes & Control 3/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine